Sfoglia per Autore
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients
2015 G. Procopio, I. Testa, E. Verzoni, R. Iacovelli, P. Grassi, G. Galli, F. De Braud, D. Saravia, R. Salvioni
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapies
2015 D. Serpico, L. Porcu, A. Tessari, A. Gevorgyan, G. Bregni, G. Galli, F. de Braud, V. Torri, S. Di Cosimo
Trastuzumab cardiac toxicity : A problem we put our heart into
2016 G. Bregni, G. Galli, A. Gevorgyan, F. De Braud, S. Di Cosimo
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer
2016 A. Gevorgyan, G. Bregni, G. Galli, M. Ganzinelli, A. Martinetti, S.L. Vullo, L. Mariani, F. Festinese, E. Sottotetti, F. De Braud, S. Di Cosimo
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
2016 A. Gevorgyan, G. Bregni, G. Galli, E. Zanardi, F. De Braud, S. Di Cosimo
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional study
2017 G. Galli, A. Tessari, L. Porcu, G. Bregni, B. Paolini, M.L. Carcangiu, M. Gennaro, M.C. De Santis, L. Lozza, F. de Braud, S. Di Cosimo
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
2017 G. Galli, G. Bregni, S. Cavalieri, L. Porcu, P. Baili, A. Hade, F. Di Salvo, M. Sant, R. Agresti, M. Gennaro, S. Folli, M.C. De Santis, B. Paolini, M.L. Carcangiu, F. De Braud, S. Di Cosimo
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : results from Neo-ALTTO
2018 S. Di Cosimo, C. Campbell, H.A. Azim, G. Galli, G. Bregni, G. Curigliano, C. Criscitiello, M. Izquierdo, L. de la Pena, D. Fumagalli, L. Fein, J. Vinholes, W.M.J. Ng, M. Colleoni, A. Ferro, B.J. Naume, A. Patel, J. Huober, M.J. Piccart-Gebhart, J. Baselga, E. de Azambuja
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors : a case series and literature review
2018 G. Galli, G. Corrao, M. Imbimbo, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, M. Vitali, F. de Braud, M.C. Garassino, G. Lo Russo
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
2018 G. Lo Russo, A. Tessari, M. Capece, G. Galli, F. de Braud, M.C. Garassino, D. Palmieri
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
2018 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, M. Vitali, M. Ganzinelli, C. Lanti, G. Molino, F. Stangoni, N. Zilembo, F. de Braud, M. Garassino, D. Signorelli
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial
2019 C. Vernieri, D. Signorelli, G. Galli, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, G. Vandoni, C. Gavazzi, T. Triulzi, M.P. Colombo, A.M. Rizzo, P.A. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer
2019 G. Galli, T. Triulzi, C. Proto, D. Signorelli, M. Imbimbo, M. Poggi, G. Fucà, M. Ganzinelli, M. Vitali, D. Palmieri, A. Tessari, F. de Braud, M. Garassino, M. Colombo, G. Lo Russo
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
2019 G. Mariani, G. Galli, S. Cavalieri, P. Valagussa, G. Bianchi, G. Capri, S. Cresta, L. Ferrari, S. Damian, M. Duca, F. de Braud, A. Moliterni
Metformin plus /- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma : The FAME trial
2019 G. Galli, D. Signorelli, C. Vernieri, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, C. Gavazzi, A.M. Rizzo, P. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019 C. Proto, R. Ferrara, D. Signorelli, G. Lo Russo, G. Galli, M. Imbimbo, A. Prelaj, N. Zilembo, M. Ganzinelli, L. Pallavicini, I. De Simone, M. Colombo, A. Sicad, V. Torri, M. Garassino
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer
2019 G. Galli, C. Proto, M. Cossa, B. Valeri, S. Sdao, D. Signorelli, M. Imbimbo, F. de Braud, M. Garassino, G. Lo Russo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile